NCT02641860View on ClinicalTrials.gov

Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

Mesenchymal progenitor cells

Biological: Allogenic Adipose tissue-derived mesenchymal progentior cells administrated for intra-articular use

Trial Locations (1)

200127

Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China, Shanghai

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

lead

Shanghai AbelZeta Ltd.

INDUSTRY

NCT02641860 - Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter